Neurocrine Biosciences, Inc. (NBIX)
142.70
-0.59
(-0.41%)
USD |
NASDAQ |
Oct 23, 16:00
142.71
+0.01
(+0.01%)
After-Hours: 20:00
Neurocrine Biosciences Price : 142.70 for Oct. 23, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 23, 2026 | 142.74 | 143.83 | 140.90 | 142.70 | 1.033M |
| Oct 22, 2026 | 141.62 | 143.83 | 140.75 | 143.29 | 1.245M |
| Oct 21, 2026 | 141.38 | 142.77 | 140.84 | 141.31 | 815513.0 |
| Oct 20, 2026 | 138.51 | 142.09 | 137.90 | 142.00 | 1.258M |
| Oct 19, 2026 | 136.34 | 137.53 | 135.00 | 136.98 | 1.050M |
| Oct 16, 2026 | 137.86 | 138.20 | 135.55 | 135.71 | 1.127M |
| Oct 15, 2026 | 137.26 | 138.23 | 135.55 | 136.95 | 1.379M |
| Oct 14, 2026 | 133.94 | 136.57 | 132.25 | 135.91 | 1.507M |
| Oct 13, 2026 | 139.60 | 139.92 | 134.89 | 135.13 | 1.568M |
| Oct 12, 2026 | 142.37 | 143.62 | 140.89 | 141.37 | 1.092M |
| Oct 09, 2026 | 141.33 | 143.55 | 140.02 | 142.44 | 1.020M |
| Oct 08, 2026 | 142.88 | 143.02 | 140.34 | 141.25 | 1.237M |
| Oct 07, 2026 | 145.33 | 145.88 | 143.21 | 143.47 | 1.144M |
| Oct 06, 2026 | 145.56 | 145.77 | 141.39 | 145.51 | 1.450M |
| Oct 05, 2026 | 142.94 | 146.92 | 142.48 | 144.21 | 1.748M |
| Oct 02, 2026 | 141.41 | 144.56 | 140.36 | 143.18 | 1.648M |
| Oct 01, 2026 | 140.94 | 143.74 | 139.61 | 140.71 | 2.052M |
| Sep 30, 2026 | 138.33 | 142.91 | 137.63 | 141.84 | 1.847M |
| Sep 29, 2026 | 138.26 | 141.07 | 136.31 | 138.35 | 1.499M |
| Sep 28, 2026 | 137.76 | 140.59 | 136.78 | 140.44 | 1.432M |
| Sep 25, 2026 | 138.94 | 138.94 | 137.02 | 138.40 | 1.171M |
| Sep 24, 2026 | 138.54 | 140.63 | 137.00 | 138.94 | 1.169M |
| Sep 23, 2026 | 141.97 | 142.24 | 139.32 | 139.49 | 1.748M |
| Sep 22, 2026 | 144.17 | 144.26 | 141.78 | 142.25 | 1.214M |
| Sep 21, 2026 | 146.15 | 146.26 | 143.45 | 143.96 | 1.385M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Amgen, Inc. | 439.26 |
| BioCryst Pharmaceuticals, Inc. | 7.65 |
| Halozyme Therapeutics, Inc. | 125.63 |
| Iovance Biotherapeutics, Inc. | 14.09 |
| Precigen, Inc. | 6.19 |
Price Related Metrics
| PE Ratio | 20.91 |
| PS Ratio | 4.375 |
| PEG Ratio | 0.206 |
| Price to Book Value | 3.925 |
| Price to Free Cash Flow | 18.18 |
| Earnings Yield | 4.78% |
| Market Cap | 14.50B |
| PEGY Ratio | 0.206 |
| Operating PE Ratio | 18.31 |
| Normalized PE Ratio | 21.33 |